# Dyne Therapeutics, Inc. (DYN): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Dyne Therapeutics, Inc. (DYN) is 11/100, ranked against 24,000+ stocks in 35 markets (Quality 25, Value 27, Momentum 34, each scored against its sector).

- StockRank: 11/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 25, Value 27, Momentum 34: each a 0-100 percentile within Healthcare.
- Position: #23,456 overall, #2,234 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 15.72 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 197K; directors sold USD 113.9M.

Source: https://moatmap.ai/stock/DYN
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker